ãããð
@kusuriusi109ç±æ¥ã®ç£ãŸãããŠã»ã£ãã»ãã®è¬å€åž«ð 調å€è¬å±
2024幎11æ5æ¥ åžåè£œè¬ ã±ããããã§ã³ããŒã40mgããã€ã³ã¯ãã»ãããXR120mgããã€ã³ã¯ããäŸçµŠåæ¢ã«é¢ãããè©«ã³ãšãç¥ãã teikoku.co.jp/med_database/fâŠ
æ£è ãããšè¬å€åž«ãããã€ãªãããã¡ã§ã®è¬ç®±ãã·ãªãŒãºã äœæ¥æ§ãšé éã«ç¹åããããè¬ã»ãã¬ãŒã¿ãŒã å® é 䟿å°çšããã¯ã¹ã«ããã£ã¡ãåãŸããå±ããç®±ã¯ãã®ãŸãŸMyãè¬ç®±ãšããŠã䜿ããŸãã #cusuri #åŠæ¹è¬ #å® æ¥äŸ¿ã³ã³ãã¯ã #ãªã³ã©ã€ã³æè¬æå°
ãã«ã¢ã®ã·ãã¯ãã€ã®å¯ŸåŠæ³ã«é¢ããè³æããããã«ãŸãšãŸã£ãŠãŠæåããŸãã mds.terumo.co.jp/diabetes/pdf/gâŠ
ð°è¥æè¬å€åž«ç ä¿®è¬åº§ð° ååã¯åŸçºçã®èšç®ã«ã€ããŠãããŸããã®ã§ãä»åã¯åŸçºå»è¬å調å€äœå¶å ç®ãäŸã«å ç®ã®å±åºã®åºæ¬çãªèãæ¹ããŸãšããŸããðŠ åºæ¬ã«ãŒã«ãç解ããŠãªããšïŒã¶æåã®å ç®ãæšãŠãããšã«ãªããŸããç¹ã«éžå®çé€ã§åŸçºçã®äžæããŠããä»ã®ææã¯æ°ãä»ããŸããã
ã€ã¯ãã©ã¹ïœè¬å€åž«éå®ã®ç¥èãèšé²ã»æ€çŽ¢ã»å ±æããWebãµã€ã
@yakuterrace2åç³å°¿ç æ²»çè¬ "ãã«ãªã·ãã£(äžè¬åïŒãã¥ã©ã°ã«ãã)ç®äžæ³š"ã¯PT-INRã延é·ãããå¯èœæ§ããããŸãã ãã®ãã"ã¯ã«ãã¡ãªã³K"ãšã¯äœµçšæ³šæãšãªã£ãŠãŸãâ 䜵çšãšãªãæ£è ããã«ã¯åºè¡åŸåã®å¯äœçšãé«ãŸãå¯èœæ§ãããããšãäŒããŸãããã
æ°äººè¬å€åž«çšïŒåæ²ïŒ éå€æçšæã«é»è²äŸ¿ã«ãªãçç± ãçç±ã ææ³ãããéçšã§éãé žåãŸãã¯é£ç©çãšã®åå¿ã«ãã䟿ãé»è²ã«ïŒ æ害ã§ã¯ãªãããæ£è ããã«ã¯ããããã説æãð çç±ãç解ãããšå¿ãã«ããã®ã§ãäžèšåèã«ã©ãã æ£è ãããåèŠãªãããã¯ãªããã¯ãð±
â è¬ã®å匷ã·ãªãŒãº ãåå²éã¢ããé žè£œå€ã®éãã¯ïŒã ãã(BCAA) ã»ãªãŒãã¯ã ã»ã¢ããã¬ãã³EN æ é€çŽ ã®æ§æã«ããéãã¯ãã¡ãââ
å»çã®éãšã¯äœãâŠããã¯ä»ãŸã§æ£è åžæã§åºãããå çºå»è¬åã®å šé¡å ¬è²»ãä¿éºã§æ¶ããŠãã£ãéãè¬ä»£ãäžçæ¯æããªã奎ãšãã§ããããã
ã¯ãœãã«ãã€ã¹æè¬ãããð¡âŒïž âå šå¡ãå šå¡ã«ãããªããšããŠãèš³ç¡ãã ããåŸé«éœ¢è ã«å¯ŸããŠã¯ãœãã«ãã€ã¹ã§è©±ããªããšããïŒãïŒããšèãè¿ãããŠé¢åãªã®ãèœã¡ãã åœç¶è¥ã人ãšãè¬ã®å 容ã¿ãŠã¯å°å£°ãéžã¶ããã
ã¢ãŒã©ã¹ããŒã40mg63æã®éžå®çé€è²»ãçŽ50åãã©ã¹ãä»ã®ãšãããããããããªãæãããã§GEãžã®å€æŽæ£è ã¯ãŒãã§ããçŸå Žããã¯ä»¥äžã§ãã
ã¯ããïŒïŒïŒçå®çå®çå®çå®ïŒïŒïŒïŒããããã«è»¢ãã£ãŠããããªèªåã«éœåã®è¯ããçå®ããçå®ã£ãŠèšã匵ãã®ãããŠãããŸããããïŒïŒïŒïŒïŒïŒïŒ
â GLP-1 (GIP/GLP-1) äœéA1cãžã®å¹æãŸãšãâ åGLP-1 (GIP/GLP-1) vs ãã©ã»ãå šRCTã®ãããã¯ãŒã¯ã¡ã¿è§£æãããšã«äœå³ããŠããŸããèæèŠãšéããšããããããŸãããåèããŒã¿ãšããŠã掻çšäžããð bmj.com/content/bmj/suâŠ
â GLP-1æç®è¡šâ å šRCT(第3çžè©Šéš)ã®ã¡ã¿è§£æïŒGLP-1BMJ. 2024;384:e076410ïŒãããŒã¹ã«äœæããŠããŸããGLP-1å士ã®çŽæ¥æ¯èŒRCTã¯å°ãªãã®ãšãæèŠçã«ïŒãªãšãããããã®ã§ããæèŠããã ãããšå¹žãã§ãððð pubmed.ncbi.nlm.nih.gov/38286487/
â GLP-1æç®è¡šâ å šRCT(第3çžè©Šéš)ã®ã¡ã¿è§£æïŒGLP-1BMJ. 2024;384:e076410ïŒãããŒã¹ã«äœæããŠããŸããGLP-1å士ã®çŽæ¥æ¯èŒRCTã¯å°ãªãã®ãšãæèŠçã«ïŒãªãšãããããã®ã§ããæèŠããã ãããšå¹žãã§ãððð pubmed.ncbi.nlm.nih.gov/38286487/
â è¬ã®å匷ã·ãªãŒãº ãïŒã€ã®å»ç°è¬ã®éãã¯ïŒã ã»ã«ã«ãã·ã¹ãã€ã³ (ã ã³ãã€ã³) ã»ã¢ã³ããããœãŒã« (ã ã³ãœã«ãã³) 詳ããã¯ãã¡ãââ
ãã«ãŒãã¡ã€ã€ãŒé¿éšïœç³å°¿ç å°éã®è¬å€åž«ïœãã¡ããã£ã³è¬åž«ïœ@ã€ãªãè¬å±
@ABESHI_WISEãSGLT2é»å®³è¬ãæ°Žåè£çµŠ ãæ°Žåããã£ãããšæã£ãŠãã ãããã ãã§ã¯ãªããæ°Žåã®éãå 容ã«ã€ããŠå ·äœçã«æå°ããŸãããâŒïž â éïŒæäžåæïŒå°¿éå¢å æïŒã¯æ¥é ã®é£²æ°ŽéïŒ500mL â å 容ïŒç³è³ªå ¥ã飲æãé¿ããæ°Žããè¶ã§è£çµŠ ïŒåèïŒ SGLT2é»å®³è¬æ£è æå°ç®ïŒJSNPçïŒ jsnp.org/ckd/sglt2_sogaâŠ
æ°äººãè¥æã®è¬å€åž«ããå¿ èŠðâŒïž ãŽãŒã¹ããã«ã£ãŠç¥ã£ãŠãâ ðââïžãããã§ãžãã³ãåŠæ¹ãããŸããã ðŠãåããŠã®äººã ãããŽãŒã¹ããã«ã®èª¬æãããããâŒïžã ðââïžãããããŽãŒã¹ããã«ãªãã§ããâïžã ãŽãŒã¹ããã«ã¯åŸæŸæ§è£œå€ã®äžã€ã§ããâŠ
ãARBãšMRAã®å¿äžå šãžã®æãããªå¹æçºçŸææã¯ïŒã CHARMè©ŠéšãšEMPHASIS-HFè©Šéšã®ãµã解æ â ARB(ã«ã³ããµã«ã¿ã³)ã¯15æ¥ç® â MRA(ãšãã¬ã¬ãã³)ã¯24æ¥ç® äœçšéã§ããããã®å¹æãèªããããããšã瀺åãããŠããŸãã äœçšéã§ãç æ ã«åãããŠãã§ããéãæ©æã«å¿äžå šæ²»çè¬ãéå§ããŸãããâŒïž
ãã«ã«ãã£ã¹ã«å«ãŸããæ·»å å€ãã¡ã°ã«ãã³ãã¯ã¢ã¹ããªã³è žæº¶é ã®ã³ãŒãã£ã³ã°å€ãã¡ã¿ã¯ãªã«é žã³ããªããŒããšåå¿ã圢ç¶ãå€åããããšãããã å»çè¬åŠ2018;44:333-40. jstage.jst.go.jp/article/jjphcsâŠ
éžå®çé€ã®è©³çŽ°ããã£ã€ãåºãŸããã
United States Trends
- 1. #UFC309 299Â B posts
- 2. Jon Jones 171Â B posts
- 3. Jon Jones 171Â B posts
- 4. Jon Jones 171Â B posts
- 5. Chandler 87,8Â B posts
- 6. Oliveira 72Â B posts
- 7. Kansas 23Â B posts
- 8. #discorddown 6.809 posts
- 9. Bo Nickal 8.982 posts
- 10. Do Bronx 11Â B posts
- 11. Arod 2.152 posts
- 12. #BYUFootball 1.396 posts
- 13. Rock Chalk 1.395 posts
- 14. Tennessee 55,5Â B posts
- 15. Dana 258Â B posts
- 16. #MissUniverse 436Â B posts
- 17. #kufball 1.092 posts
- 18. Keith Peterson 1.358 posts
- 19. Big 12 1.783 posts
- 20. Oregon 34,3Â B posts
Something went wrong.
Something went wrong.